awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q38438503-29E20663-F489-411C-A80F-DB0CC1E139EC
Q38438503-29E20663-F489-411C-A80F-DB0CC1E139EC
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38438503-29E20663-F489-411C-A80F-DB0CC1E139EC
The times they are a-changin': new antibacterials for skin and skin structure infections.
P2860
Q38438503-29E20663-F489-411C-A80F-DB0CC1E139EC
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38438503-29E20663-F489-411C-A80F-DB0CC1E139EC
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
665cc1d358af7fb2bbc4e6cd7351514060708245
P2860
Phase 2, randomized, double-blind, dose-ranging study evaluating the safety, tolerability, population pharmacokinetics, and efficacy of oral torezolid phosphate in patients with complicated skin and skin structure infections.